Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I
B. I. Eriksson, O. E. Dahl, L. Ahnfelt, P. Kälebo, J. Stangier, G. Nehmiz, K. Hermansson, V. KohlbrennerVolume:
2
Year:
2004
Language:
english
Pages:
8
DOI:
10.1111/j.1538-7836.2004.00890.x
File:
PDF, 154 KB
english, 2004